Mairi McLean

Medicine & Life Sciences

1. Interleukin-27 100%
2. Inflammatory Bowel Diseases 74%
3. Colitis 54%
4. Microbiota 51%
5. CAP18 lipopolysaccharide-binding protein 43%
6. Organoids 42%
7. Neoplasms 34%
8. Adenomatous Polyps 33%
9. Polyps 33%
10. Interleukins 33%
11. Helicobacter pylori 30%
12. Stomach Neoplasms 29%
13. Cytokines 28%
14. Adenoma 28%
15. interleukin-22 28%
16. teduglutide 28%
17. Colorectal Neoplasms 28%
18. Dysbiosis 27%
19. trichlorosucrose 25%
20. Innate Immunity 23%
21. Mucous Membrane 23%
22. Ileitis 22%
23. Semaphorins 21%
24. Inflammation 21%
25. Toll-Like Receptor 9 21%
26. Helicobacter 21%
27. Sweetening Agents 20%
28. Short Bowel Syndrome 20%
29. Proteobacteria 20%
30. Ulcerative Colitis 20%
31. Stomach Diseases 20%
32. Lipocalin-2 20%
33. HMGB1 Protein 20%
34. Tissue Inhibitor of Metalloproteinases 20%
35. Colon 19%
36. Mucosal Immunity 18%
37. Barrett Esophagus 18%
38. T-Lymphocytes 18%
39. Matrix Metalloproteinase Inhibitors 18%
40. Crohn Disease 17%
41. Infliximab 17%
42. Epithelium 17%
43. Phenotype 16%
44. Gastrointestinal Diseases 16%
45. Therapeutics 15%
46. Genes 14%
47. Gastrointestinal Tract 14%
48. Virulence 14%
49. Peroxidase 14%
50. Homeostasis 14%